This diagnostic assay utilizes Fe(II)-chelated alginate nanoparticles engineered via an inverse emulsion method and stabilized by crosslinking with gelatin. Upon exposure to urine samples containing MMP2/9 enzymes, the gelatin matrix is enzymatically cleaved, releasing individual iron-bound alginate particles. Subsequent acidification liberates Fe(II) ions, which then induce a Fenton reaction with chromogenic substrates, producing a distinct color change. This simple, point-of-care readout is achieved without the need for sophisticated equipment, and the assay maintains room temperature stability, ensuring its suitability in diverse clinical and resource-limited settings.